Robert Kissinger v. HHS - Tdap, Guillain-Barré syndrome (2020)
Case summary [AI summaries can sometimes make mistakes]
Robert Kissinger filed a petition on August 4, 2017, alleging that the tetanus-diphtheria-acellular pertussis (Tdap) vaccine he received on April 5, 2016, caused him to develop Guillain-Barré syndrome (GBS). He further alleged that the residual effects of this injury persisted for more than six months.
The Tdap vaccine is listed on the Vaccine Injury Table. Respondent denied that the vaccine caused petitioner's alleged injury or any other injury.
Despite the denial, the parties reached a stipulation. The Special Master adopted the stipulation, awarding Mr.
Kissinger a lump sum of $22,500.00 as compensation for all damages. The decision was issued on October 28, 2020.
Petitioner was represented by Lawrence S. Paikoff, and Respondent was represented by Colleen C.
Hartley. Special Master Christian J.
Moran issued the decision.
Theory of causation
Petitioner Robert Kissinger alleged that the Tdap vaccine received on April 5, 2016, caused Guillain-Barré syndrome (GBS), with residual effects lasting more than six months. The Tdap vaccine is listed on the Vaccine Injury Table. Respondent denied causation. The parties reached a stipulation, which Special Master Christian J. Moran adopted. The stipulation awarded petitioner a lump sum of $22,500.00 for all damages. Petitioner was represented by Lawrence S. Paikoff, and Respondent was represented by Colleen C. Hartley. The decision date was October 28, 2020.
Source PDFs
USCOURTS-cofc-1_17-vv-01063